Pembrolizumab is under clinical development by Merck and currently in Phase I for Kaposi Sarcoma. According to GlobalData, Phase I drugs for Kaposi Sarcoma have an 84% phase transition success rate ...

These statistics include both adults and children. Certain types occur more often in certain parts of the body more often than others. For example, leiomyosarcomas are the most common type of sarcoma ...

About 3,770 new cases diagnosed (2,150 in males and 1,620 in females) About 2,190 deaths (1,240 in males and 950 in females) This includes cancers in both children and adults. Primary bone cancers ...